MedPath

LOTUS INTERNATIONAL PTE. LTD.

🇸🇬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

72

HSA:72

Drug Approvals

DESROXIA FILM-COATED TABLETS 360MG

Approval Date
Feb 6, 2025
HSA

DESROXIA FILM-COATED TABLETS 90MG

Approval Date
Feb 6, 2025
HSA

GRALISE EXTENDED RELEASE TABLETS 600 MG

Approval Date
Jan 16, 2025
HSA

GRALISE EXTENDED RELEASE TABLETS 300 MG

Approval Date
Jan 16, 2025
HSA

CONJUPRI TABLETS 2.5MG

Approval Date
Dec 26, 2024
HSA

CONJUPRI TABLETS 5MG

Approval Date
Dec 26, 2024
HSA

ABRAD FILM COATED TABLET 7.5 MG

Approval Date
Jul 31, 2024
HSA

ABRAD FILM COATED TABLET 5 MG

Approval Date
Jul 31, 2024
HSA

NEUROFIND PROLONGED RELEASE TABLETS 54 MG

Approval Date
Jun 5, 2024
HSA

NEUROFIND PROLONGED RELEASE TABLETS 36 MG

Approval Date
Jun 5, 2024
HSA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.